Yoshida J - Search Results

1

Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles.

Ito A, Shinkai M, Honda H, Yoshikawa K, Saga S, Wakabayashi T, Yoshida J, Kobayashi T. Ito A, et al. Among authors: yoshida j. Cancer Immunol Immunother. 2003 Feb;52(2):80-8. doi: 10.1007/s00262-002-0335-x. Epub 2003 Jan 29. Cancer Immunol Immunother. 2003. PMID: 12594571 Free PMC article.

2

Effective solitary hyperthermia treatment of malignant glioma using stick type CMC-magnetite. In vivo study.

Ohno T, Wakabayashi T, Takemura A, Yoshida J, Ito A, Shinkai M, Honda H, Kobayashi T. Ohno T, et al. Among authors: yoshida j. J Neurooncol. 2002 Feb;56(3):233-9. doi: 10.1023/a:1015080808031. J Neurooncol. 2002. PMID: 12061729

3

Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells.

Nakahara N, Pollack IF, Storkus WJ, Wakabayashi T, Yoshida J, Okada H. Nakahara N, et al. Among authors: yoshida j. Cancer Gene Ther. 2003 Jul;10(7):549-58. doi: 10.1038/sj.cgt.7700598. Cancer Gene Ther. 2003. PMID: 12833135

4

Interferon-beta gene therapy for cancer: basic research to clinical application.

Yoshida J, Mizuno M, Wakabayashi T. Yoshida J, et al. Cancer Sci. 2004 Nov;95(11):858-65. doi: 10.1111/j.1349-7006.2004.tb02194.x. Cancer Sci. 2004. PMID: 15546502 Free article. Review.

5

Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen.

Ohno M, Natsume A, Ichiro Iwami K, Iwamizu H, Noritake K, Ito D, Toi Y, Ito M, Motomura K, Yoshida J, Yoshikawa K, Wakabayashi T. Ohno M, et al. Among authors: yoshida j. Cancer Sci. 2010 Dec;101(12):2518-24. doi: 10.1111/j.1349-7006.2010.01734.x. Epub 2010 Sep 30. Cancer Sci. 2010. PMID: 20880333 Free article.

6

A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy.

Wakabayashi T, Natsume A, Hashizume Y, Fujii M, Mizuno M, Yoshida J. Wakabayashi T, et al. Among authors: yoshida j. J Gene Med. 2008 Apr;10(4):329-39. doi: 10.1002/jgm.1160. J Gene Med. 2008. PMID: 18220319 Clinical Trial.

7

A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation.

Natsume A, Wakabayashi T, Ishii D, Maruta H, Fujii M, Shimato S, Ito M, Yoshida J. Natsume A, et al. Among authors: yoshida j. Cancer Chemother Pharmacol. 2008 Apr;61(4):653-9. doi: 10.1007/s00280-007-0520-x. Epub 2007 Jun 13. Cancer Chemother Pharmacol. 2008. PMID: 17564708

8

Epigenetic aberrations and therapeutic implications in gliomas.

Natsume A, Kondo Y, Ito M, Motomura K, Wakabayashi T, Yoshida J. Natsume A, et al. Among authors: yoshida j. Cancer Sci. 2010 Jun;101(6):1331-6. doi: 10.1111/j.1349-7006.2010.01545.x. Epub 2010 Mar 15. Cancer Sci. 2010. PMID: 20384628 Free article. Review.

9

Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor.

Takasu S, Takahashi T, Okamoto S, Oriuchi N, Nakayashiki N, Okamoto K, Muramatsu H, Hayashi T, Nakahara N, Mizuno M, Wakabayashi T, Higuchi T, Endo K, Kozaki K, Miyaishi O, Saga S, Ueda R, Yoshida J, Yoshikawa K. Takasu S, et al. Among authors: yoshida j. J Neurooncol. 2003 Jul;63(3):247-56. doi: 10.1023/a:1024320516341. J Neurooncol. 2003. PMID: 12892230

10

[Glioma].

Wakabayashi T, Natsume A, Yoshida J. Wakabayashi T, et al. Among authors: yoshida j. Nihon Rinsho. 2006 Jul;64(7):1327-32. Nihon Rinsho. 2006. PMID: 16838652 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,411 results

Search Page